The first AIDS therapeutic vaccine will be available

According to the "New Scientist" magazine website on the 22nd, recently in the United States in Seattle, the retrovirus and opportunistic infection meeting, Spain's IrsiCAixa AIDS Institute Beadris Moss announced a surprising new treatment for AIDS Sexual Vaccine Clinical Trial Results: Virus replication in five HIV (HIV) carriers was not only successfully inhibited, but the time to stop taking antiretroviral drugs (ART) exceeded 4 weeks for the first time, one of which even reached 7 months. Long.

According to the February 24 news, in order to prevent the virus from causing damage to the immune system, HIV-infected people need to take ART every day or even for life. Although taking ART has been shown to be effective in suppressing AIDS episodes, these drugs are expensive, time consuming, and have serious side effects.

Three years ago, Moser led the team to conduct human clinical trials on two HIV vaccines developed at the University of Oxford in the United Kingdom. At that time, 24 newly diagnosed HIV-infected people participated in the trial. They all took ART drugs to test whether the vaccine could be stimulated. A strong immune response.

比尔·盖茨投资新型植入型给药装置,预防艾滋病

This time, Moser designed a new test procedure for 15 of them, first giving them a large dose of one of the vaccines; then injecting a three-fold dose of the anticancer drug romidepsin, which has been proven Effectively remove HIV that is lurking in the body; finally, give each person a large dose of another vaccine and stop taking ART.

Mask-Peel off Mask

Mask-Peel Off Mask,Face Mask,Approved Mask,Approved Facemask

Guangzhou Lingxue Cosmetics Co., Ltd , https://www.gzlxgj188.com